Xiaoliang Jiang | Molecular Biology | Best Scholar Award

Published on by Shen Awards

Prof. Dr. Xiaoliang Jiang | Molecular Biology | Best Scholar Award

Professor of Physiology from Institute of Laboratory Animal Sciences, China

Professor Jiang Xiaoliang is a distinguished researcher and Master’s Supervisor at the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences. Born in March 1987, he has built an impressive career in cardiovascular research, laboratory animal sciences, and molecular mechanisms underlying hypertension and cardiac disorders. With over a decade of dedicated research, he has contributed significantly to understanding the role of epigenetic regulation, signal transduction pathways, and disease modeling. His extensive experience in both national and international institutions has led to numerous high-impact publications in prestigious journals such as Advanced Science, Hypertension, and the Journal of the American Heart Association. Additionally, he has successfully led and participated in major research projects funded by the National Natural Science Foundation of China and the Chinese Academy of Medical Sciences. Professor Jiang’s work demonstrates a seamless integration of experimental pathology, physiology, and translational medicine. His contributions have been recognized through several awards and honors, affirming his role as a leading scholar in his field. Jiang’s continuous commitment to innovation and excellence marks him as a highly suitable candidate for distinguished research awards. His profile reflects both depth and breadth of expertise, making him a role model for aspiring scientists.

Professional Profile

Education

Professor Jiang Xiaoliang has pursued a focused and prestigious educational path aligned with his research interests in pathology, physiology, and biological sciences. He obtained his Ph.D. in Pathology and Pathophysiology from the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences, between September 2011 and July 2014. His doctoral studies allowed him to develop an in-depth understanding of disease mechanisms at the molecular and cellular levels, particularly within the cardiovascular system. Before his Ph.D., he earned his M.S. in Physiology from the same institute between September 2009 and July 2011, further enhancing his knowledge of bodily functions and their disruptions in disease states. His academic journey began with a B.S. in Biological Science from Shandong Normal University, completed from September 2005 to July 2009. This strong foundational background equipped him with a broad knowledge of biological principles, critical thinking skills, and experimental methodologies, setting the stage for his later specialized training. Throughout his education, Professor Jiang demonstrated academic excellence and a commitment to scientific inquiry. His educational trajectory reflects a consistent dedication to advancing his expertise in biomedical sciences, perfectly positioning him for a leading role in cutting-edge medical research.

Professional Experience

Professor Jiang Xiaoliang’s professional career is deeply rooted in the Institute of Laboratory Animal Sciences at the Chinese Academy of Medical Sciences, where he has progressively advanced through academic and research roles. Currently, he serves as a Researcher since December 2024, leading key projects and supervising postgraduate research. Previously, he was an Associate Researcher from July 2018 to December 2024, where he contributed to significant research programs and established a strong reputation in cardiovascular and hypertension research. From January 2014 to July 2018, he worked as an Assistant Researcher, during which he honed his skills in experimental design, molecular biology techniques, and disease modeling. Notably, Professor Jiang also gained international experience as a Research Assistant at the University of Maryland School of Medicine, Department of Nephrology, from August 2012 to January 2014. This exposure to an international research environment broadened his perspectives and enriched his scientific approaches. Across all his roles, Professor Jiang has demonstrated outstanding leadership, technical expertise, and a passion for translational research. His career progression reflects a consistent commitment to excellence, making significant contributions to the fields of laboratory animal science and cardiovascular medicine.

Research Interests

Professor Jiang Xiaoliang’s research interests focus primarily on cardiovascular diseases, molecular and cellular mechanisms of hypertension, cardiac hypertrophy, renal physiology, and laboratory animal model development. He is particularly interested in the epigenetic regulation of cardiac reprogramming, the role of ion channels in blood pressure regulation, and the impact of neurohormonal factors on cardiovascular health. His work explores how pathways like PI3K/Akt, PKC-mediated signaling, and Na+/H+ exchangers contribute to disease pathology, and how these mechanisms can be targeted therapeutically. Additionally, he has investigated the interplay between salt sensitivity, inflammation, and oxidative stress in the development of hypertension. Another key area of his research includes the establishment and refinement of animal models for infectious and cardiovascular diseases, aiding in the development of new therapeutic interventions. His focus on translational medicine bridges basic research findings with potential clinical applications. Furthermore, Jiang has demonstrated a keen interest in the interactions between dopamine receptor pathways and cardiovascular-renal function. Through his research, he aims to uncover novel insights that can lead to innovative treatments for complex and critical diseases.

Research Skills

Professor Jiang Xiaoliang possesses an extensive array of research skills that have greatly enhanced his scientific contributions. His expertise includes molecular biology techniques such as gene editing, nucleic acid delivery, and signal transduction pathway analysis. He is proficient in developing and utilizing animal models for cardiovascular and infectious disease studies, a critical skill in translational medicine. Jiang has demonstrated advanced capabilities in histopathology, immunohistochemistry, real-time PCR, Western blotting, and other biochemical assays essential for mechanistic studies. He is highly skilled in the analysis of epigenetic modifications and their effects on gene expression, particularly concerning cardiac reprogramming and vascular biology. Additionally, his experience includes the application of pharmacological interventions and gene therapy techniques to elucidate disease pathways and therapeutic targets. Professor Jiang’s international research experience has provided him with strong data management, statistical analysis, and collaborative project management skills. His ability to design, implement, and analyze complex experiments underscores his strength in bridging basic research with clinical relevance. Through his technical proficiency and innovative approach, Jiang continues to push the boundaries of biomedical research.

Awards and Honors

Professor Jiang Xiaoliang’s outstanding contributions to science have been recognized through numerous prestigious awards and honors. In 2022, he was awarded the “Young International Award” by the Japanese Association for Laboratory Animal Science, a testament to his significant impact on the field at an early career stage. Additionally, he received the Second Prize of the Science and Technology Achievement Award from the Chinese Association for Laboratory Animals for his role in the “Creation and Application of Animal Models for Cardiovascular Diseases.” Another notable recognition was the Second Prize of the Hebei Provincial Science and Technology Progress Award in 2019, for his work on the regulation of the Renin-Angiotensin System in multiple organ injuries. Jiang was also selected for the highly competitive Youth Talent Support Project (YESS20170157) under the China Association for Life Sciences, where he secured ¥450,000 in funding for innovative research from 2017 to 2019. These honors reflect Professor Jiang’s consistent excellence, innovation, and leadership in biomedical research. His recognition by national and international bodies illustrates his important role in advancing scientific knowledge and his strong potential for future groundbreaking contributions.

Conclusion

In conclusion, Professor Jiang Xiaoliang stands out as a highly qualified and accomplished scholar in the field of biomedical sciences, particularly cardiovascular research and laboratory animal science. His educational background, combined with extensive professional experience and a strong record of research achievements, positions him as a leader and innovator in his discipline. His ability to secure competitive funding, produce high-impact publications, and contribute meaningfully to collaborative research initiatives highlights both his scientific capabilities and leadership qualities. Professor Jiang’s recognition through various prestigious awards further attests to his contributions to the advancement of science. His research exhibits a rare combination of depth, innovation, and translational relevance. Areas where he might further strengthen his profile include expanding international collaborations and leading multi-center studies to enhance global scientific impact. Overall, Professor Jiang’s impressive career trajectory, commitment to excellence, and passion for discovery make him a strong and deserving candidate for the Best Scholar Award in Research. He embodies the qualities of an outstanding researcher who continues to make significant contributions to medical science and inspire the next generation of scientists.

Publications Top Notes

  1. Title: Enpp1 Ameliorates MAFLD by Regulating Hepatocyte Lipid Metabolism Through the AMPK/PPARα Signaling Pathway

    • Authors: Liu Xiaohui, Chen Shuai, Liu Xing, Li Yuhan, Yang Zhiwei

    • Year: 2025

  2. Title: Intestinal Gastrin/CCKBR Axis Protects Against Type 2 Diabetes by Reducing Intestinal Glucose Absorption Through the PI3K/Akt/eIF4B Signaling Pathway

    • Authors: Liu Xue, Liu Xing, Liu Yunpeng, Zhang Haizeng, Yang Zhiwei

    • Year: 2025

Fu Xiaocong | Molecular Biology | Best Innovation Award

Published on by Shen Awards

Mr. Fu Xiaocong | Molecular Biology | Best Innovation Award

Shanghai Paisi Xin Biopharmaceutical Technology Co., Ltd. Malaysia

Dr. Xiaocong Fu is a highly accomplished Senior Tumor Immunology Researcher with more than a decade of experience in the development of cell therapy and gene/nucleic acid-based therapeutics. Currently based in Shanghai, he holds a PhD and has served in both academic and industrial roles, including as Founder of PSM Biotech and Associate Professor at Taylor’s University. His career encompasses a broad range of translational research activities with a strong focus on clinical immunology, drug mechanism validation, and precision oncology. He has published over 30 academic papers, with 13 as the first author in SCI-indexed journals, and holds more than nine personal invention patents. Dr. Fu is certified in GCP, CAP auditing, and biosafety regulations, with additional advisory roles in AI research and biotechnology projects. His multifaceted expertise includes immune function analysis, CAR-T/TCR-T method development, and organoid model systems, all of which reflect his dedication to innovation and real-world impact. His unique ability to combine clinical relevance with scientific discovery positions him as a leading figure in the field of tumor immunology and a strong candidate for prestigious innovation and research awards.

Professional Profile

Education

Dr. Xiaocong Fu holds a Doctorate in Tumor Immunology, which has laid the scientific foundation for his highly specialized career in immunotherapy research. In addition to his academic training in immunology, he pursued advanced studies in business and innovation management at the China Europe International Business School, equipping him with a strategic understanding of biotech commercialization and research leadership. This interdisciplinary educational background has uniquely positioned him to integrate laboratory innovation with real-world therapeutic applications. His formal training includes rigorous technical and regulatory coursework, exemplified by certifications in Good Clinical Practice (GCP) and clinical trial quality management. Dr. Fu has also completed specialized training in biosafety and laboratory quality systems, including certification from the Shanghai Biosafety Training and Assessment Program and the College of American Pathologists (CAP). These credentials have enabled him to oversee clinical laboratory standards and contribute to high-stakes regulatory audits and clinical research. His academic affiliation with Taylor’s University as an Associate Professor further demonstrates his commitment to continuous learning, academic mentorship, and scientific excellence. The combination of scientific rigor and managerial insight distinguishes Dr. Fu’s educational journey and reflects his preparedness to drive complex, multidisciplinary projects in immunology and therapeutic development.

Professional Experience

Dr. Xiaocong Fu’s professional journey spans more than a decade of progressive responsibility in both industry and academia, reflecting a strong blend of translational research and entrepreneurial leadership. From 2012 to 2019, he worked at Shanghai WuXi AppTec Co., Ltd., where he played a critical role in preclinical and clinical immunology research. His responsibilities included the development of orthotopic tumor models, pharmacokinetic/pharmacodynamic studies, immune function assays, and clinical biomarker validation. During this time, he built expertise in flow cytometry, immune subpopulation analysis, and organoid construction platforms. As Technical Director of the CAP Clinical Center, Dr. Fu successfully developed and validated multiple clinical methods, including those for CAR-T therapies and phosphorylation-related biomarker detection. His current roles include Founder of PSM Biotech, where he leads innovation in cell and gene therapy platforms, and Associate Professor at Taylor’s University, where he contributes to academic research and mentorship. He also serves as Vice President of the Jiangxi Chamber of Commerce and holds advisory roles with AI research institutes. Dr. Fu’s professional scope covers scientific innovation, quality control, clinical trial management, and biotech entrepreneurship, establishing him as a multifaceted leader in the biomedical and pharmaceutical research sectors.

Research Interests

Dr. Xiaocong Fu’s research interests lie at the forefront of tumor immunology, cell therapy development, and translational clinical science. His primary focus is on understanding the mechanisms of immune response in cancer, particularly through the development and validation of CAR-T and TCR-T therapies. He is deeply involved in immune-mediated killing analyses, including ADCC (antibody-dependent cellular cytotoxicity), CDC (complement-dependent cytotoxicity), ADCP (antibody-dependent cellular phagocytosis), and TLR (toll-like receptor) functions. Dr. Fu also explores immune phenotyping and biomarker discovery, especially in relation to hematological malignancies and solid tumors. Another key area of interest is the use of induced pluripotent stem cells (iPSCs) for disease modeling and drug response simulation, with his team constructing organoid platforms for more precise in vitro analyses. Additionally, he is passionate about integrating gene editing technologies such as CRISPR to develop immune cell-based models that mimic in vivo responses. Dr. Fu’s interests extend to clinical pharmacology, biomarker-based patient stratification, and receptor occupancy studies, all aimed at creating more effective, personalized therapeutic strategies. His research is inherently translational, bridging the gap between laboratory innovation and clinical application to improve patient outcomes in cancer immunotherapy.

Research Skills

Dr. Xiaocong Fu possesses a wide array of advanced research skills that make him a standout contributor in the field of tumor immunology and clinical translational research. He is proficient in both in vitro and in vivo assays, including the development of orthotopic tumor models and functional immune assays. He has mastered multiparameter flow cytometry and is capable of operating high-throughput cytometry instruments such as the BD Fortessa X-20 and Canto systems, applying panels with up to 18 colors. His skill set includes the quantitative analysis of intracellular and extracellular signaling molecules, using detection platforms like Cytometric Bead Array (CBA) and Meso Scale Discovery (MSD). Dr. Fu is experienced in gene editing using CRISPR/Cas9 technologies, having successfully developed monoclonal iPSCs with precise gene knock-ins/knockouts. In clinical pharmacology, he has validated several PK/PD methods for CAR-T therapies and phosphorylation biomarkers. His technical leadership extends to immunophenotyping of both lymphoid and myeloid subpopulations, receptor occupancy assays, and biomarker tracking. He is also adept at clinical laboratory quality systems, having contributed to CAP audits and biosafety program implementations. These diverse, high-level research skills have enabled him to lead multidisciplinary projects across discovery, validation, and clinical translation domains.

Awards and Honors

Throughout his career, Dr. Xiaocong Fu has received numerous accolades that highlight his commitment to excellence and innovation in biomedical research. While specific award titles are not listed in the provided profile, his recognition can be inferred from his leadership roles and scientific achievements. His appointment as an Associate Professor at Taylor’s University, a position typically awarded to individuals with significant academic contributions, underscores his research credibility. His selection as a CAP auditor and a GCP-certified clinical trial manager reflects the high level of trust regulatory and research bodies place in his judgment and technical competence. As the Founder of PSM Biotech, he has also been acknowledged for his entrepreneurial efforts in translating immunological science into therapeutic platforms. Moreover, his advisory role in AI-based scientific projects further demonstrates peer recognition of his interdisciplinary expertise. With over 13 first-author SCI publications and nine personal invention patents, Dr. Fu’s body of work stands as a testament to sustained scholarly and innovative output. These milestones serve as informal yet powerful recognitions of his contributions, suggesting that he is not only a subject matter expert but also a recognized leader in his field.

Conclusion

Dr. Xiaocong Fu exemplifies the fusion of scientific excellence, clinical relevance, and innovative thinking necessary to transform cancer therapy through immune system modulation. His rich educational background, expansive professional experience, and cutting-edge research portfolio position him at the forefront of biomedical innovation. From pioneering CAR-T and TCR-T therapies to constructing iPSC-based organoid models, his work covers the full spectrum of research from basic science to translational application. As a skilled researcher, technical leader, and biotech entrepreneur, Dr. Fu has developed and validated multiple clinical methodologies, driven discovery in tumor immunology, and fostered collaborations across academia, industry, and regulatory agencies. His research consistently addresses real-world challenges in oncology and immunotherapy, leveraging both molecular precision and systems-level insight. Although there is room to expand his visibility in global academic networks and enhance commercialization outcomes, Dr. Fu’s existing contributions are both impactful and future-focused. He is a model candidate for honors such as the Best Innovation Award in Research and represents the caliber of researcher who not only advances knowledge but also changes lives through science.

Maizura Murad | Biological Sciences | Best Researcher Award

Published on by Shen Awards

Dr. Maizura Murad | Biological Sciences | Best Researcher Award

Lecturer and researcher from University Sains Malaysia, Malaysia

Dr. Maizura Murad is a distinguished academic specializing in food sensory analysis, food processing, and the antioxidant properties of food. Since June 25, 2013, she has been serving at the School of Industrial Technology, Universiti Sains Malaysia (USM). In her role, Dr. Maizura provides invaluable assistance and supervision to both undergraduate and postgraduate students, particularly in the realm of food sensory analyses. Her dedication to research is evident through her numerous publications in international peer-reviewed journals, focusing on sensory evaluations of food. Beyond her academic pursuits, Dr. Maizura is committed to advancing the field of food science, contributing significantly to the understanding of how food processing impacts sensory qualities and antioxidant properties. ​

Professional Profile

Education

Dr. Maizura Murad’s academic journey reflects her deep commitment to the field of food science and technology. She earned her Bachelor of Science degree in Food Quality Management from Universiti Teknologi MARA (UiTM) in Malaysia. Pursuing further specialization, she obtained her Master’s degree in Food Technology from Universiti Sains Malaysia (USM). Culminating her formal education, Dr. Maizura achieved a Ph.D. in Food Science from Universiti Kebangsaan Malaysia (UKM). This robust educational foundation has equipped her with comprehensive knowledge and expertise, enabling her to make significant contributions to the field of food sensory analysis and processing. ​

Professional Experience

Dr. Maizura Murad has been an integral part of Universiti Sains Malaysia (USM) since June 25, 2013, where she serves at the School of Industrial Technology. In her capacity, she supervises and mentors both undergraduate and postgraduate students, particularly in the area of food sensory analyses. Her role encompasses not only teaching but also guiding research projects that delve into the sensory evaluation of food products. Dr. Maizura’s professional experience is marked by her dedication to fostering a comprehensive understanding of food processing and its impact on sensory qualities, thereby preparing her students to excel in the food science industry. ​

Research Interests

Dr. Maizura Murad’s research interests are centered around food sensory analysis, food processing, and the antioxidant properties of food. She is particularly intrigued by how different processing methods influence the sensory attributes and nutritional quality of food products. Her work aims to bridge the gap between food processing techniques and consumer perception, ensuring that processed foods meet both quality standards and consumer expectations. By focusing on antioxidant properties, Dr. Maizura contributes to the development of healthier food options, emphasizing the importance of nutrition alongside sensory appeal. ​

Research Skills

Dr. Maizura Murad possesses a robust set of research skills honed through years of academic and professional experience. Her expertise lies in conducting comprehensive food sensory evaluations, utilizing both qualitative and quantitative methodologies to assess consumer preferences and perceptions. She is adept at designing and implementing experiments that explore the effects of various food processing techniques on sensory attributes and antioxidant properties. Dr. Maizura’s proficiency in statistical analysis enables her to interpret complex data effectively, drawing meaningful conclusions that contribute to the advancement of food science. ​

Awards and Honors

Specific details regarding awards and honors received by Dr. Maizura Murad are not readily available in the provided sources. However, her extensive publication record in international peer-reviewed journals and her longstanding role at Universiti Sains Malaysia (USM) reflect her esteemed position in the academic community. Her contributions to food sensory analysis and processing have undoubtedly garnered recognition and respect among her peers and students alike. ​

Conclusion

Dr. Maizura Murad’s dedication to the field of food science is evident through her extensive research, teaching, and mentorship roles at Universiti Sains Malaysia (USM). Her expertise in food sensory analysis, processing, and antioxidant properties has significantly contributed to the understanding of how processing techniques affect food quality and consumer perception. By bridging the gap between scientific research and practical applications, Dr. Maizura plays a pivotal role in advancing food technology and ensuring the development of nutritious and appealing food products. ​

Publications Top Notes

  • Title: Total phenolic content and antioxidant activity of kesum (Polygonum minus), ginger (Zingiber officinale) and turmeric (Curcuma longa) extract
    Authors: M. Maizura, A. Aminah, W.M. Wan Aida
    Year: 2011
    Citations: 438

  • Title: Antibacterial activity and mechanical properties of partially hydrolyzed sago starch–alginate edible film containing lemongrass oil
    Authors: M. Maizura, A. Fazilah, M.H. Norziah, A.A. Karim
    Year: 2007
    Citations: 382

  • Title: Physical and mechanical properties of sago starch–alginate films incorporated with calcium chloride
    Authors: A. Fazilah, M. Maizura, A. Abd Karim, K. Bhupinder, B. Rajeev
    Year: 2011
    Citations: 71

  • Title: Film Incorporated with Lemongrass (Cymbopogon citratus) Oil
    Authors: M. Maizura, A. Fazilah, M.H. Norziah, A.A. Karim
    Year: 2008
    Citations: 47

  • Title: Physicochemical properties and sensory acceptability of pineapples of different varieties and stages of maturity
    Authors: R. Siti Rashima, M. Maizura, W.M. Wan Nur Hafzan, H. Hazzeman
    Year: 2019
    Citations: 33

  • Title: The use of salt-coating to improve textural, mechanical, cooking and sensory properties of air-dried yellow alkaline noodles
    Authors: S.Y. Yeoh, M. Lubowa, T.C. Tan, M. Murad, A.M. Easa
    Year: 2020
    Citations: 32

  • Title: Influence of sodium chloride treatment and polysaccharides as debittering agent on the physicochemical properties, antioxidant capacity and sensory characteristics of bitter melon
    Authors: R. Siti Rashima, M. Maizura, W.M. Kang, A. Fazilah, L.X. Tan
    Year: 2017
    Citations: 30

  • Title: The development of legume-based yogurt by using water kefir as starter culture
    Authors: X.X. Lim, W.Y. Koh, U. Uthumporn, M. Maizura, W.I. Wan Rosli
    Year: 2019
    Citations: 26

  • Title: Physico-chemical and antioxidant properties of eggplant flour as a functional ingredient
    Authors: U. Uthumporn, A. Fazilah, A.Y. Tajul, M. Maizura, A.S. Ruri
    Year: 2016
    Citations: 26

  • Title: A review of natural cheese and imitation cheese
    Authors: A. Mohd Shukri, A.K. Alias, M. Murad, K.S. Yen, L.H. Cheng
    Year: 2022
    Citations: 22

 

Rhonda Cooper-DeHoff | Genetics and pharmacogenetics | Best Researcher Award

Published on by Shen Awards

Dr. Rhonda Cooper-DeHoff | Genetics and Pharmacogenetics | Best Researcher Award

Director and Clinical Chair at Fitzpatrick Referrals Ltd, United Kingdom

Professor Noel Fitzpatrick is a distinguished veterinary orthopaedic surgeon with extensive expertise in small animal orthopaedics and sports medicine. Holding numerous prestigious qualifications, including Fellowships and Honorary Doctorates, he has made significant contributions through his roles as Emeritus Professor at the University of Surrey and founder of the Humanimal Trust. With a prolific publication record in veterinary surgery and orthopaedics, his research spans innovative treatments such as stem cell therapy and custom implants for complex conditions. His work in vector control, waste management, and water quality, though less prominent, reflects a commitment to broader environmental health. Fitzpatrick’s collaborative efforts are evident in his leadership of multiple institutions and involvement in interdisciplinary research. Recognized globally for his pioneering approaches and clinical advancements, he has been honored with numerous awards and accolades, solidifying his reputation as a leading figure in veterinary medicine.

Education

Dr. Rhonda M. Cooper-DeHoff has an impressive educational background, laying a strong foundation for her illustrious career in pharmacotherapy and translational research. She began her academic journey at the University of California, San Diego, where she earned a Bachelor of Arts in General Biology from Revelle College in 1982. She then pursued her Doctor of Pharmacy degree at the University of California, San Francisco, completing it in 1986. Dr. Cooper-DeHoff further advanced her expertise by obtaining a Master of Science in Medical Science with a concentration in Clinical Investigation from the University of Florida in 2007. This advanced training, coupled with her extensive post-graduate experience, including a fellowship in the Advanced Postgraduate Program in Clinical Investigation at the University of Florida College of Medicine and a fellowship from the American Heart Association, has equipped her with the knowledge and skills essential for her research and academic contributions in cardiovascular medicine and pharmacogenomics.

Professional Experience

Dr. Rhonda M. Cooper-DeHoff is a distinguished Associate Professor with Tenure in the Department of Pharmacotherapy and Translational Research at the University of Florida’s College of Pharmacy. Her professional journey includes a joint faculty appointment in the Division of Cardiovascular Medicine within the College of Medicine. Dr. Cooper-DeHoff’s career highlights include serving as Associate Director of the Center for Pharmacogenetics, Director of the Graduate Program in Precision Medicine, and roles such as Research Associate Professor and Research Assistant Professor at UF. Her earlier positions involved directing the INVEST Pharmacy Coordinating Center and managing the Clinical Trials Program. Dr. Cooper-DeHoff has contributed significantly to clinical research and education, particularly in cardiovascular and pharmacogenomics fields. Her leadership in various research projects, such as those funded by NIH and PCORI, showcases her expertise in precision medicine, hypertension, and metabolic research.

Research Interests

Dr. Rhonda M. Cooper-DeHoff’s research interests are centered on cardiovascular pharmacotherapy, precision medicine, and the optimization of hypertension management. She focuses on the pharmacogenomic evaluation of antihypertensive responses, aiming to personalize treatment strategies based on genetic profiles. Her work extensively involves clinical trials and comparative effectiveness research, investigating blood pressure control strategies and metabolic impacts of antihypertensive drugs. Dr. Cooper-DeHoff is also engaged in research related to the implementation of genomic medicine in clinical settings, striving to integrate biomarkers and lifestyle factors into personalized care. Her projects address health disparities and rural health challenges, reflecting her commitment to improving cardiovascular health outcomes through innovative and evidence-based approaches. Through her research, Dr. Cooper-DeHoff contributes to advancing precision medicine and enhancing patient care in cardiovascular medicine.

Research Skills

Dr. Rhonda M. Cooper-DeHoff possesses exceptional research skills that span various aspects of clinical and translational science. Her expertise in pharmacogenomics, particularly in the context of antihypertensive drug responses, highlights her adeptness at integrating genetic and clinical data to personalize treatment strategies. Dr. Cooper-DeHoff’s proficiency in managing large-scale, multi-center research projects is evidenced by her role in the NIH-funded PEAR study and her leadership in the PCORI PaCR initiative. Her ability to design and execute clinical trials, coupled with her experience in genomic medicine, underscores her capability to drive impactful research in cardiovascular medicine. Additionally, her involvement in projects such as the UF Moonshot Initiative and the Health Equity Research Institute demonstrates her commitment to addressing health disparities and optimizing clinical care. Dr. Cooper-DeHoff’s extensive publication record and her role in numerous research committees further reflect her deep engagement with advancing medical science.

Awards and Recognition

Dr. Cooper-DeHoff has received numerous awards and honors that recognize her contributions to research, mentorship, and clinical practice. Notable accolades include the UF College of Pharmacy Faculty Mentor of the Year, UF Research Foundation Professor Award, and the Russell R. Miller Award from the American College of Clinical Pharmacy. These awards reflect her excellence and leadership in the field.

Conclusion

Dr. Rhonda M. Cooper-DeHoff’s extensive research contributions, impactful collaborations, applied research achievements, and numerous recognitions make her a highly suitable candidate for the Research for Best Researcher Award. Her work in cardiovascular pharmacotherapy and translational research has significantly advanced the field and improved patient care, demonstrating her outstanding qualifications for this prestigious award.

Publications Top Notes

  1. Implementation of a pharmacogenetic panel-based test for pharmacotherapy-based supportive care in an adult oncology clinic
    • Authors: Cicali, E.J., Eddy, E., Gong, Y., George, T.J., Cooper-DeHoff, R.M.
    • Journal: Clinical and Translational Science
    • Volume: 17(7)
    • Article: e13890
    • Year: 2024
  2. Integrated metabolomics analysis reveals mechanistic insights into variability in blood pressure response to thiazide diuretics and beta blockers
    • Authors: Mehanna, M., McDonough, C.W., Smith, S.M., Johnson, J.A., Cooper-DeHoff, R.M.
    • Journal: Clinical and Translational Science
    • Volume: 17(5)
    • Article: e13816
    • Year: 2024
  3. Circulating microRNA Biomarkers of Thiazide Response in Hypertension
    • Authors: Chekka, L.M.S., Tantawy, M., Langaee, T., Cooper-Dehoff, R.M., Johnson, J.A.
    • Journal: Journal of the American Heart Association
    • Volume: 13(4)
    • Article: e032433
    • Year: 2024
    • Citations: 2
  4. Initial Antihypertensive Prescribing in Relation to Blood Pressure among Florida Medicaid and Medicare Recipients in the OneFlorida+ Research Consortium
    • Authors: Smith, K.M., Keshwani, S., Walsh, M.G., Cooper-Dehoff, R.M., Smith, S.M.
    • Journal: Hypertension
    • Volume: 81(2)
    • Pages: E7-E9
    • Year: 2024
  5. Characteristics and Predictors of Apparent Treatment-Resistant Hypertension in Real-World Populations Using Electronic Health Record-Based Data
    • Authors: Jafari, E., Cooper-DeHoff, R.M., Effron, M.B., Hogan, W.R., McDonough, C.W.
    • Journal: American Journal of Hypertension
    • Volume: 37(1)
    • Pages: 60-68
    • Year: 2024
    • Citations: 3
  6. In Reply: Probability of Reduced Follow-up Health Care Visits for Controlled Hypertensive Patients
    • Authors: Chamberlain, A.M., Cooper-DeHoff, R.M., Pletcher, M.J.
    • Journal: Mayo Clinic Proceedings
    • Volume: 98(6)
    • Pages: 949
    • Year: 2023
  7. Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale
    • Authors: Joseph, J., Pajewski, N.M., Dolor, R.J., Shivaswamy, V., Ramalingam, R.
    • Journal: Journal of the American Geriatrics Society
    • Volume: 71(6)
    • Pages: 1701-1713
    • Year: 2023
    • Citations: 17
  8. New Drugs Approved in 2022
    • Authors: Ebied, A.M., Elmariah, H., Cooper-DeHoff, R.M.
    • Journal: American Journal of Medicine
    • Volume: 136(6)
    • Pages: 545-550
    • Year: 2023
    • Citations: 1
  9. Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline-Based Chemotherapy
    • Authors: Deremer, D.L., Nguyen, N.K., Guha, A., Fradley, M.G., Gong, Y.
    • Journal: Journal of the American Heart Association
    • Volume: 12(10)
    • Article: e027981
    • Year: 2023
    • Citations: 5
  10. Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory
    • Authors: Chamberlain, A.M., Cooper-DeHoff, R.M., Fontil, V., Knowlton, K.U., Pletcher, M.J.
    • Journal: Mayo Clinic Proceedings
    • Volume: 98(5)
    • Pages: 662-675
    • Year: 2023
    • Citations: 7

 

Anam | Genetics and Molecular Biology | Best Scholar Award

Published on by Shen Awards

Mrs. Anam | Genetics and Molecular Biology | Best Scholar Award

P.hD Biochemistry research scholar  of University of lucknow,lucknow and ICAR-Indian institute of sugarcane research,lucknow, India .

Mrs. Anam is a dedicated researcher with expertise in biotechnology and biochemistry. She holds a Master’s degree in Biotechnology and Chemistry and is currently pursuing a Ph.D. in Biochemistry at the University of Lucknow, India. Mrs. Anam’s research interests encompass molecular biology, biochemical pathways, and biotechnological applications, with a focus on advancing scientific knowledge in these areas. She has valuable professional experience as a Young Professional-1 in the Plant Physiology and Biochemistry Division at ICAR-Indian Institute of Sugarcane Research, where she contributes to cutting-edge research projects. Mrs. Anam’s skills include experimental design, molecular biology techniques, biochemical assays, and data analysis. She is passionate about scientific inquiry, evidenced by her participation in research training programs and academic pursuits. Mrs. Anam’s dedication to research and her multidisciplinary skill set position her as a promising researcher in the field of biotechnology and biochemistry.

Professional Profiles:

Education

Mrs. Anam has attained notable educational qualifications in biotechnology and chemistry, underscoring her commitment to academic excellence and expertise in scientific disciplines. She completed a Master of Science (M.Sc) in Biotechnology, focusing on advanced molecular biology, genetics, and biotechnological applications. This postgraduate degree equips her with specialized knowledge essential for research and development in the biotechnology sector. Additionally, Mrs. Anam holds Bachelor of Science (B.Sc) degrees in Biotechnology and Chemistry, providing a strong foundation in biological sciences and chemical principles. This interdisciplinary educational background enhances her understanding of biochemical processes and their practical applications. Mrs. Anam’s academic achievements reflect her dedication to acquiring comprehensive skills and knowledge necessary for success in biotechnology, research, and laboratory work.

Professional Experience

Mrs. Anam possesses a wealth of professional experience in the dynamic field of biotechnology and biochemistry. Currently pursuing a Ph.D. in Biochemistry at the University of Lucknow, she is actively engaged in advanced research focusing on biochemical processes and their applications in biological systems. As a Young Professional-1 in the Plant Physiology and Biochemistry Division at ICAR-Indian Institute of Sugarcane Research, Lucknow, Mrs. Anam contributes to cutting-edge research projects in plant physiology, biochemistry, and agricultural biotechnology. Her role involves hands-on experimentation and analysis, further enhancing her expertise in applied biotechnological research. Previously, she was selected as a BCIL Trainee through the Biotechnology Industry Training Programme (BITP) by the Department of Biotechnology (DBT), Government of India, and completed a specialized industrial training program at AquaBiochip Genomics India Pvt. Ltd., Biotech Park, Lucknow. These experiences underscore Mrs. Anam’s proficiency in scientific research, laboratory techniques, and industry-relevant applications within the biotechnology field. Her diverse professional journey reflects a strong commitment to advancing knowledge and innovation in biotechnology and biochemistry.

Research Interest

Mrs. Anam’s research interests are diverse and encompass key areas of biotechnology and biochemistry. She is particularly focused on molecular biology, investigating gene expression and cellular processes. Additionally, Mrs. Anam is interested in exploring biochemical pathways and their impact on metabolism and cellular regulation. She is keen on biotechnological applications, aiming to develop innovative solutions for agriculture, healthcare, and environmental sustainability. Her passion extends to immunology and infectious diseases, with a focus on host-pathogen interactions and immune system modulation. In her current role in plant physiology research, Mrs. Anam seeks to understand plant biochemistry to enhance crop productivity and resilience. Through her multidisciplinary approach, she aims to contribute to scientific advancements that address critical societal and environmental challenges.

Award and Honors

Mrs. Anam has been recognized for her academic achievements and dedication to scientific inquiry in biotechnology and biochemistry. Her selection as a BCIL Trainee through the Biotechnology Industry Training Programme (BITP) by the Department of Biotechnology (DBT), Government of India, signifies her academic excellence and potential in biotechnological applications. As a Ph.D. researcher in Biochemistry at the University of Lucknow, Mrs. Anam demonstrates a strong commitment to advanced research and scholarly pursuits. While specific awards and honors may vary, these achievements highlight her academic merit and contributions to the field. Mrs. Anam’s pursuit of excellence in biotechnology and biochemistry positions her as a promising researcher with the potential for further recognition and impactful contributions to the scientific community.

Research Skills

Mrs. Anam possesses a diverse and comprehensive skill set in research methodologies essential for biotechnology and biochemistry. She excels in experimental design, molecular biology techniques (DNA isolation, PCR), biochemical assays (enzyme kinetics, protein analysis), and cell culture. Mrs. Anam is adept at data analysis using statistical tools and bioinformatics software to derive meaningful insights from experimental data. She demonstrates strong scientific writing skills for manuscript preparation and grant proposals, supported by her ability to conduct thorough literature reviews. Proficient in operating laboratory instrumentation and managing research projects, Mrs. Anam exhibits a well-rounded approach to scientific inquiry. Her expertise equips her to contribute significantly to advancing knowledge and innovation in biotechnology, biochemistry, and related fields. Mrs. Anam’s research skills underscore her potential for impactful contributions to scientific research and development endeavors.